AstraZeneca

Amylink

Awakening belief. Accelerating change.

AstraZeneca set out to lead a bold new movement in the fight against amyloidosis, which is a rare, often overlooked cause of heart failure. But leadership knew science alone wouldn’t be enough. The brand behind their evidence development program needed to do more than inform; it needed to awaken belief, unite global collaborators, and inspire confidence across clinical audiences.

amylink logo
Font showcase of Komet Bold for amylink style guide
Two people hugging and smiling
pink and orange gradient star, amylink logo
Various thumbnails of the amylink Logo style guide
amylink posts in a social app on a cell phone
amylink branded cover slide template on a desktop
  • purple and blue amylink branded header slide template
  • amylink branded chart slide template
  • purple and blue with orange accents amylink branded header slide template
  • blue amylink branded header slide template
  • amylink branded slide template
  • orange amylink branded header slide template
  • amylink branded closing slide template

The challenge

How do you create momentum around a disease most clinicians have never seen?

Amyloidosis is underdiagnosed and poorly understood, leaving awareness low and clinical urgency even lower. Determined to lead the fight against amyloidosis, AstraZeneca needed to close that gap and fast. With the high-profile ESC Congress approaching, the brand had to introduce its program in a way that not only educated but also motivated action and built lasting credibility among specialists, researchers, and global partners.

The solution

A brand designed to unify, inform, and inspire.

We developed Amylink as a strategic umbrella brand grounded in the science of amyloidosis and built to connect collaborators across studies, disciplines, and geographies. The name set the tone for a visual and verbal identity rooted in clarity, connection, and momentum that was brought to life at ESC Congress through immersive tools that sparked conversation and strengthened AstraZeneca’s leadership position.

The results

Momentum that ignites a movement.

Amylink launched as AstraZeneca’s platform for global connection, scientific leadership, and sustained commitment to patients with amyloidosis. It inspired belief, built urgency, and created space for collaboration across a field ready for change.

Today, Amylink continues to serve as a trusted, scalable identity, powering AstraZeneca’s partnerships, communications, and innovation for advancements in the amyloidosis space.

Ready to make your mark?

You have the vision. We have the expertise to make it real. From pharmaceuticals to technology and consumer goods, we’ve created some of the world’s most recognizable and iconic brands.

Let’s awaken your brand together.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

*Required